%0 Journal Article %T Serum Fibroblast Growth Factor 21 and New-Onset Metabolic Syndrome: KoGES-ARIRANG Study %A Il Hwan Park %A Jang-Young Kim %A Ji Hye Huh %A Jong Taek Park %A Joon Hyung Sohn %A Jung Ran Choi %A Ki Woo Kim %A Kyu-Sang Park %A Sang Baek Koh %A Seung-Kuy Cha %J Archive of "Yonsei Medical Journal". %D 2018 %R 10.3349/ymj.2018.59.2.287 %X Fibroblast growth factor 21 (FGF21) is a crucial metabolic regulator, with multiple favorable effects on glucose homeostasis and lipid metabolism. Since serum FGF21 level has been implicated as a potential marker for the early identification of metabolic syndrome (MetS), we investigated the association between serum FGF21 level and the development of MetS in a population-based prospective study %K Metabolic syndrome %K fibroblast growth factor 21 %K biomarker %K population-based prospective study %U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5823832/